Skip to main content
. Author manuscript; available in PMC: 2018 Jan 10.
Published in final edited form as: Circulation. 2016 Nov 23;135(2):153–165. doi: 10.1161/CIRCULATIONAHA.116.025471

TABLE 1.

Baseline characteristics of the MESA sample (N=3,733) and the SPRINT-eligible subsample (N= 1,394), according to baseline blood pressure (BP) therapy

MESA Study Sample P-value* Sprint-Eligible Subsample P-value*
No BP Therapy (N= 1964) BP Therapy (N= 1769) No BP Therapy (N= 613) BP Therapy (N= 781)
Age, years 63.4 (±9.9) 66.1 (±9.3) <0.001 69.0 (±7.9) 69.4 (±7.8) 0.51
Male 1004 (51) 796 (45) <0.001 412 (67) 401 (51) <0.001
Race <0.001 <0.001
 White 757 (38) 548 (31) 253 (41) 280 (36)
 Black 505 (26) 700 (40) 148 (24) 278 (36)
 Hispanic 464 (24) 349 (20) 139 (23) 146 (19)
 Chinese 238 (12) 172 (10) 73 (12) 77 (10)
Body Mass Index, kg/m2 28.3 (±5.3) 29.8 (±5.6) <0.001 27.7 (±4.6) 28.8 (±5.32) <0.001
Systolic BP, mmHg 137.2 (±13.4) 141.2 (±14.1) <0.001 147.2 (±12.3) 148.4 (±12.2) 0.035
Diastolic BP, mmHg 76.2 (±8.8) 75.6 (±9.5) 0.02 78.5 (±9.0) 77.6 (±9.6) 0.17
Fasting Glucose, mg/dL 97.0 (±30.7) 103.8 (±33.0) <0.001 92.1 (±10.5) 93.7 (±11.4) 0.01
Diabetes 174 (9) 385 (22) <0.001 - -
Smoking Status <0.001 <0.001
 Current Smoker 269 (14) 167 (9) 88 (14) 80 (10)
 Never Smoker 942 (48) 932 (53) 249 (40) 391 (50)
 Former Smoker 747 (38) 661 (38) 273 (45) 306 (40)
LDL-C, mg/dL 120.8 (±30.9) 113.4 (±31.1) <0.001 125.1 (±30.8) 116.7 (±30.9) <0.001
HDL-C, mg/dL 51.2 (±14.9) 50.4 (±14.1) 0.18 48.8 (±14.2) 50.7 (±14.3) <0.005
Triglycerides, mg/dL 116 (79-164) 113 (81-166) 0.92 122 (87-166) 113 (83-165) 0.12
Creatinine, mg/dL 0.94 (±0.21) 1.0 (±0.29) <0.001 1.01 (±0.22) 1.04 (±0.28) 0.07
Family History of MI 771 (42) 801 (49) <0.001 238 (43) 359 (50) 0.001
10 year ASCVD Risk, % 14 (±11) 22 (±0.15) <0.001 21 (±22) 24 (±12) <0.001
ASCVD Risk Score Categories <0.001 <0.001
 <7.5% 683 (35) 276 (16) 23 (4) 29 (4)
 7.5-15% 552 (28) 402 (23) 192 (32) 160 (21)
 >15% 716 (37) 1072 (61) 393 (65) 584 (75)

Values are for number (%), median (IQR) or mean (±SD)

*

P values are for differences between groups using 1-way ANOVA, Kruskal Wallis testing, or χ2, as appropriate.

ASCVD indicates atherosclerotic cardiovascular disease; BP, blood pressure; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; MESA, multi-ethnic study of atherosclerosis; and MI, myocardial infarction.